EW Buy/LongTechnical analysis of the company. According to financial indicators, the company is currently undervalued and is supported by SMA200. The target price for the company is $88.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.47 USD
874.60 M USD
5.44 B USD
575.05 M
About Edwards Lifesciences Corporation
Sector
Industry
CEO
Bernard J. Zovighian
Website
Headquarters
Irvine
Founded
1958
ISIN
US28176E1082
FIGI
BBG000BRXP69
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Related stocks
UPC courtEdwards Lifesciences' recent win at the UPC is a crucial development that could ensure the company's profitability from its invention throughout a large number of European nations.
Edwards Lifesciences Enters the GapHealthcare has been the weakest sector in the past year, but some traders may expect a comeback in Edwards Lifesciences.
The first pattern on today’s chart is the breakout on Friday after earnings and revenue beat estimates. That rally brought EW into a bearish gap from one year ago.
Second is th
EW EARNINGS TRADE SETUP
📈 EW EARNINGS TRADE SETUP (07/24) 📈
💥 Quiet stock, loud opportunity. Fundamentals strong. Market asleep. We’re not.
🧠 Quick Read:
• Beat rate: 88% over 8 quarters
• Margins elite (OP Margin: 29%, Net: 75.7%)
• RSI 43 → Neutral setup with room to run
• Big OI at $80 calls (6.7k+) 💪
• IV not bloated
Edwars lifesciences: ready for a bull runAfter a sharpe decline the NYSE:EW stock rebounded and now it seems to be ready for a new bull run.
Actually the P&F chart reversed bullish in august, and after one month of trading range it gave another strong buy signal in october, with the quadruple-top at 73.
At the current price of 74 t
breaking high, NICE ENTRY POINT FOR BUYINGGREAT breaking resistence level, for swing trade. good Risk Reward
(EW) edward lifesciencesblood company, they have a warehouse based here in Utah, only reason I know of the company; as it turns out they did reach an all-time high and drop. Too bad. Wonder what happened? They were doing so well.
Buy at 86,19 after the rejectionTHIS IS NOT SHORT IDEA!!! Expecting a fall to 86,19 and rejection back to the final target. Enter just after clear rejection on 4H chart. Then set conditional SL, if any two 4H candles closes below the SL zone, cutloss your trade. No rejection at 86,19 = no trade. Don´t fall to the trap by buying lo
EW Flagging Just Under Major PivotEW is flagging beautifully just under the major $87 pivot. Made two nice gaps up after a similar flag broke to the upside. Showing great relative strength on a nasty market day as well. Target $95
Edwards Stop Buy placedAs seen on the chart - stop buy order placed. If the next bullish move comes I take it to the next level ....
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US28176EAD0
Edwards Lifesciences Corporation 4.3% 15-JUN-2028Yield to maturity
4.23%
Maturity date
Jun 15, 2028
See all EW bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Edwards Lifesciences Corporation stocks are traded under the ticker EW.
We've gathered analysts' opinions on Edwards Lifesciences Corporation future price: according to them, EW price has a max estimate of 101.00 USD and a min estimate of 72.00 USD. Watch EW chart and read a more detailed Edwards Lifesciences Corporation stock forecast: see what analysts think of Edwards Lifesciences Corporation and suggest that you do with its stocks.
Yes, you can track Edwards Lifesciences Corporation financials in yearly and quarterly reports right on TradingView.
Edwards Lifesciences Corporation is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
EW earnings for the last quarter are 0.67 USD per share, whereas the estimation was 0.62 USD resulting in a 7.42% surprise. The estimated earnings for the next quarter are 0.59 USD per share. See more details about Edwards Lifesciences Corporation earnings.
Edwards Lifesciences Corporation revenue for the last quarter amounts to 1.53 B USD, despite the estimated figure of 1.49 B USD. In the next quarter, revenue is expected to reach 1.50 B USD.
EW net income for the last quarter is 337.60 M USD, while the quarter before that showed 365.20 M USD of net income which accounts for −7.56% change. Track more Edwards Lifesciences Corporation financial stats to get the full picture.
No, EW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 29, 2025, the company has 15.8 K employees. See our rating of the largest employees — is Edwards Lifesciences Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Edwards Lifesciences Corporation EBITDA is 1.70 B USD, and current EBITDA margin is 29.41%. See more stats in Edwards Lifesciences Corporation financial statements.
Like other stocks, EW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Edwards Lifesciences Corporation stock right from TradingView charts — choose your broker and connect to your account.